EATG » Hepatitis

Hepatitis

In HBV, high core-related antigen levels predict cirrhosis

Elevated hepatitis B virus core-related antigen levels significantly increased the risk for progression to cirrhosis among patients with chronic hepatitis B who are hepatitis B e antigen-negative and are not…

Hepatitis D virus in Africa: several unmet needs

A systematic review and meta-analysis, published in The Lancet Global Health, assessed anti-hepatitis D virus seroprevalence in HBsAg-positive patients in sub-Saharan Africa. The full analysis can be assessed here. An…

Study shows DAAs are not associated with increased HCC recurrence risk

Direct acting antivirals (DAA) are a novel and completely oral hepatitis C therapy that is associated with a high response rate. DAAs are used in most patients being treated for…

HCV drug resistance: infrequent, and frequently overcame

Hepatitis C virus (HCV) mutations that can resist drug treatment are infrequent, and are unlikely to withstand longer treatment durations or the addition of a synergistic drug, according to new…

Malaysia issues compulsory license for Gilead hepatitis C drug

Late last month, Malaysia's government issued a compulsory license in an effort to offer a less-expensive version of Gilead's hepatitis C drug and increase access. Reports of the government move…

Two approvals offer even more options for HCV treatment

The approval of two new regimens for treating hepatitis C comes as a very welcome development in the field. It is great news for patients and providers because both regimens…

US: HIV/HCV coinfection remains marginalized despite progress

The population of patients coinfected with HIV and hepatitis C in the U.S. remains largely marginalized for one reason or another. They are opioid drug users, Medicaid recipients, men who…

Hepatitis care in substance users

News from the 6th International Symposium on Hepatitis Care in Substance Users 6 – 8 September 2017 Jersey City/New York, United States Addiction clinics need physician education, lifted restrictions to…

Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis C study in Northern Norway

Abstract Background Hepatitis C (HCV) infection causes an asymptomatic chronic hepatitis in most affected individuals, which often remains undetected until cirrhosis and cirrhosis-related complications occur. Screening of high-risk subjects in…

Study finds no significant correlation between psoriasis and prevalence of HBV and HCV

Psoriasis is a poorly understood skin disorder and auto-immune disease characterized by rapidly dividing skin cells that reach the surface of the skin, eventually leading to red plaques and scales.…